1 |
2cureX AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
2 |
2Seventy Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
3 |
3-D Matrix Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
4 |
4Basebio PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
5 |
4D Molecular Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
6 |
4Sc AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
7 |
89bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
8 |
A Science AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
9 |
AB Science SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
10 |
Abcam Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
11 |
AbCellera Biologics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
12 |
Abera Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
13 |
Abion Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
14 |
Abionyx Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
15 |
Abivax SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
16 |
ABL Bio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
17 |
Abliva AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
18 |
Ablynx NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
19 |
Absci Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
20 |
AC Immune SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
21 |
Acepodia Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
22 |
Acesis Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
23 |
Achilles Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
24 |
Aclaris Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
25 |
Acrivon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
26 |
Acticor Biotech SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
27 |
Actinium Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
28 |
Actinogen Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
29 |
Active Biotech AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
30 |
Actuate Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
31 |
Acumen Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
32 |
Acurx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
33 |
Adagene Inc (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
34 |
Adagio Medical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
35 |
Adalta Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
36 |
Adaptimmune Therapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
37 |
Adaptive Biotechnologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
38 |
ADC Therapeutics SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
39 |
Adial Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
40 |
Adicet Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
41 |
Aditxt Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
42 |
Adocia SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
43 |
Advagene Biopharma Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
44 |
Advanced Medical Equipment SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
45 |
Adverum Biotechnologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
46 |
Aeon Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
47 |
Aerovate Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
48 |
Affimed NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
49 |
Affinor Growers Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
50 |
AFYREN SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
51 |
Agalawatte Plantations PLC (Sri Lanka) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
52 |
Agile Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
53 |
Agios Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
54 |
AgResearch Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
55 |
Aileron Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
56 |
Airway Medix SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
57 |
Akari Therapeutics PLC (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
58 |
Akero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
59 |
Akeso Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
60 |
Aldeyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
61 |
Alector Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
62 |
Algernon Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
63 |
Algorae Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
64 |
Aligos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
65 |
Allakos Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
66 |
Allarity Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
67 |
Alligator Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
68 |
Allogene Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
69 |
Allovir Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
70 |
Alpha Cognition Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
71 |
Alpha IVF Group Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
72 |
Alpha Tau Medical Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
73 |
Alphamab Oncology (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
74 |
Alpine Immune Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
75 |
Altamira Therapeutics Ltd (Bermuda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
76 |
Alterola Biotech Inc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
77 |
Alvotech SA (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
78 |
Alzamend Neuro Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
79 |
AlzeCure Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
80 |
Alzinova AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
81 |
Ambrx Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
82 |
Amniotics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
83 |
Ampio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
84 |
Amplia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
85 |
AN2 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
86 |
AnaptysBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
87 |
Anatolia TaniveBytklj Unli Ar Ge SiveTiA (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
88 |
Anavex Life Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
89 |
Anebulo Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
90 |
AnGes Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
91 |
Angion Biomedica Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
92 |
Anhui Wanbang Pharmacutcl Tchnlgy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
93 |
Annovis Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
94 |
Antengene Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
95 |
Anteotech Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
96 |
Anti-Microbial Savior BioteQ Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
97 |
Antibe Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
98 |
Anya Biopharm Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
99 |
AP Biosciences Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
100 |
Apexigen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
101 |
Apogee Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
102 |
Applied BioCode Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
103 |
Applied Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
104 |
Aprea Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
105 |
AptaBio Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
106 |
Aptamer Sciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
107 |
Aptorum Group Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
108 |
Aravive Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
109 |
Arbutus Biopharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
110 |
Arcellx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
111 |
Arch Biopartners Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
112 |
Arcturus Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
113 |
Arcutis Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
114 |
Ardelyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
115 |
Argenica Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
116 |
Argent BioPharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
117 |
argenx SE (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
118 |
argenx SE - ADR (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
119 |
Aridis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
120 |
AroCell AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
121 |
Arovella Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
122 |
Arrivent Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
123 |
Arrowhead Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
124 |
ARS Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
125 |
Artelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
126 |
Arterra Bioscience SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
127 |
Artiva Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
128 |
Asarina Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
129 |
Ascelia Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
130 |
Ascendis Pharma A/S (ADR) (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
131 |
Ascentage Pharma Group International (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
132 |
Asep Medical Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
133 |
Aslan Pharmaceuticals Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
134 |
Astria Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
135 |
ATAI Life Sciences NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
136 |
Atara Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
137 |
Atea Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
138 |
Athira Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
139 |
Aton SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
140 |
Atreca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
141 |
aTyr Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
142 |
Aura Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
143 |
Aurinia Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
144 |
Autolus Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
145 |
Avacta Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
146 |
Avalo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
147 |
Avantium NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
148 |
Avecho Biotechnology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
149 |
Avenue Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
150 |
Avicanna Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
151 |
Axcella Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
152 |
Axonics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
153 |
Axsome Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
154 |
Azitra Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
155 |
BACHEM HOLDING AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
156 |
Bactiquant A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
157 |
Barinthus Biotherapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
158 |
Basilea Pharmaceutica AG Allschwil (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
159 |
Battelle Memorial Institute (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
160 |
Baudax Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
161 |
BB BIOTECH AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
162 |
Beam Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
163 |
Beijing Northland Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
164 |
Beijing Sun-Novo Pharma Research Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
165 |
Belite Bio Inc (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
166 |
Bellerophon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
167 |
Bellicum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
168 |
Benitec Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
169 |
Benson Hill Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
170 |
Bergenbio ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
171 |
Better Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
172 |
Beyondspring Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
173 |
BGI Genomics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
174 |
Bicycle Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
175 |
Bide Pharmatech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
176 |
Bio Meat Foodtech LP (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
177 |
Bio Path Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
178 |
Bio-Works Technologies AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
179 |
BioArctic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
180 |
Biodexa Pharmaceuticals PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
181 |
Biodexa Pharmaceuticals PLC-ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
182 |
Bioextrax AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
183 |
Biogend Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
184 |
BioInfra Life Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
185 |
BioInvent International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
186 |
BioLASCO Taiwan Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
187 |
BioLine RX Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
188 |
BioMark Diagnostics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
189 |
Biomea Fusion Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
190 |
Biomind Labs Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
191 |
Biomm SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
192 |
Biomx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
193 |
Bioneer Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
194 |
BioNexus Gene Lab Corp (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
195 |
Bionomics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
196 |
Bionomics Ltd - ADR (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
197 |
BioNTech SE - ADR (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
198 |
Biophytis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
199 |
Bioqual Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
200 |
BioRestorative Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
201 |
Biosergen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
202 |
Biotron Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
203 |
Biovaxys Technology Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
204 |
Bioventix PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
205 |
Biovica International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
206 |
BioXcel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
207 |
bioXXmed AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
208 |
Bioxyne Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
209 |
Bivictrix Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
210 |
Black Diamond Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
211 |
bluebird bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
212 |
Blueprint Medicines Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
213 |
Bonus Biogroup Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
214 |
Boundless Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
215 |
BPH Energy Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
216 |
BPH Global Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
217 |
BRAIN Biotech AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
218 |
Braster SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
219 |
Briacell Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
220 |
Bright Minds Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
221 |
BrightPath Biotherapeutics Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
222 |
Brii Biosciences Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
223 |
BRIM Biotechnology Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
224 |
BTB Korea Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
225 |
BTC Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
226 |
C4 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
227 |
C4X Discovery Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
228 |
Cabaletta Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
229 |
Cadrenal Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
230 |
Calcimedica Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
231 |
CAMP4 Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
232 |
CanBas Co Ltd (Parent) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
233 |
Candel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
234 |
Cannabix Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
235 |
Cannasouth Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
236 |
Cantargia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
237 |
Captor Therapeutics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
238 |
Carbios SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
239 |
Carbiotix AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
240 |
Cardio Diagnostics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
241 |
Cardiol Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
242 |
CARGO Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
243 |
Caribou Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
244 |
Carisma Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
245 |
Carmell Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
246 |
Carna Biosciences, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
247 |
Cartesian Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
248 |
Castle Creek Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
249 |
Cavendish Hydrogen ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
250 |
Ceapro Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
251 |
Celcuity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
252 |
Cell Source Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
253 |
Cellectis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
254 |
Cellivery Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
255 |
CellSeed Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
256 |
Celyad Oncology SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
257 |
Centessa Pharmaceuticals PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
258 |
Centogene NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
259 |
Century Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
260 |
Cerevel Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
261 |
CervoMed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
262 |
CG Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
263 |
Channel Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
264 |
Charles River Lbrtrs ntrntl Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/28/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
265 |
Check Cap Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
266 |
Checkpoint Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
267 |
Chemomab Therapeutics Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
268 |
ChemPartner PharmaTech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
269 |
Chimerix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
270 |
China Health Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
271 |
Chinook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
272 |
Chiome Bioscience Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
273 |
Chitogenx Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
274 |
Chordia Therapeutics Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
275 |
Cibus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
276 |
Cidara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
277 |
Circio Holding ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
278 |
Citius Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
279 |
Cizzle Biotechnology Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
280 |
Clarity Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
281 |
Clearmind Medicine Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
282 |
Clearside Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
283 |
Clene Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
284 |
Clever Culture Systems Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
285 |
Climb Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
286 |
Clinuvel Pharmaceuticals Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
287 |
CNS Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
288 |
Codexis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
289 |
Codiak BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
290 |
Cogent Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
291 |
Cognetivity Neurosciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
292 |
Cognition Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
293 |
Cogstate Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
294 |
CohBar Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
295 |
Collplant Biotechnologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
296 |
Collplant Biotechnologies Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
297 |
Combigene AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
298 |
Comera Life Sciences Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
299 |
Compass Pathways PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
300 |
Compass Therapeutics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
301 |
Conduit Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
302 |
Connect Biopharma Holdings Ltd (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
303 |
Context Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
304 |
Corestemchemon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
305 |
Corvus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
306 |
Coya Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
307 |
Creative Medical Technology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
308 |
Crescita Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
309 |
Crinetics Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
310 |
Crispr Therapeutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
311 |
CTC Centro de Tecnologia Canavieira SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
312 |
Cullinan Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
313 |
Curable Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
314 |
Curacle Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
315 |
Curasight A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
316 |
CureVac BV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
317 |
Curocell Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
318 |
Cybin Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
319 |
Cyclerion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
320 |
Cyfuse Biomedical KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
321 |
CymaBay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
322 |
Cynata Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
323 |
Cyteir Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
324 |
Cytogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
325 |
D.Western Therapeutics Institute Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
326 |
Darwin AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
327 |
Decibel Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
328 |
Defence Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
329 |
Dermata Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
330 |
Destiny Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
331 |
Deutsche Biotech Innovativ AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
332 |
Dextech Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
333 |
Diagonal Bio AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
334 |
DiaMedica Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
335 |
Diamyd Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
336 |
Dianthus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
337 |
Dicerna Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
338 |
Dicot Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
339 |
Dimerix Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
340 |
DNA Chip Research Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
341 |
DNA Group TR Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
342 |
DNA Link Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
343 |
DND Pharmatech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
344 |
Dogwood Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
345 |
Double Bond Phrmcutcl Intrntnl AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
346 |
DreamCIS Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
347 |
DV Biomed Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
348 |
Dyadic International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
349 |
Dyne Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
350 |
e-Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
351 |
Ecopro HN Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
352 |
Edesa Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
353 |
Edgewise Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
354 |
Editas Medicine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
355 |
eFFECTOR Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
356 |
EGF Theramed Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
357 |
Eiger Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
358 |
Eledon Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
359 |
ELEVAI Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
360 |
Elevation Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
361 |
Eloxx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
362 |
Emplicure AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
363 |
Emyria Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
364 |
Enanta Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
365 |
ENCell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
366 |
Endonovo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
367 |
ENDRA Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
368 |
Energenesis Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
369 |
enGene Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
370 |
Engineering Research and Consulting, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
371 |
Enimmune Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
372 |
Enlighta Inc (British Virgin Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
373 |
Enliven Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
374 |
Enlivex Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
375 |
Ensysce Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
376 |
Entera Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
377 |
Entheon Biomedical Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
378 |
Environmental Clean Technologies Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
379 |
Eone Diagnomics Genome Center Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
380 |
Epi Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
381 |
Equillium Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
382 |
Erasca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
383 |
Ergomed PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
384 |
ESSA Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
385 |
Eurofins Scientific SE (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
386 |
Eurofins-Cerep SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
387 |
European Institute of Science AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
388 |
Evaxion Biotech A/S - ADR (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
389 |
Evelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
390 |
Evogene Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
391 |
Evolus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
392 |
Evolva Holding Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
393 |
Exact Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
394 |
Exact Therapeutics AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
395 |
Exelixis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
396 |
Exicure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
397 |
Faraday Future Intelligent Electric Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
398 |
Faron Pharmaceuticals Oy (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
399 |
Femtobiomed Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
400 |
FendX Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
401 |
Fermentalg SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
402 |
Fibrobiologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
403 |
FibroGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
404 |
Finch Therapeutics Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
405 |
Fluicell AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
406 |
Fluoguide AS (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
407 |
Foresee Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
408 |
Formycon AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
409 |
Forte Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
410 |
Fortrea Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
411 |
Fractyl Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
412 |
Freeline Therapeutics Holdings PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
413 |
Frontage Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
414 |
Fulcrum Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
415 |
Fullhope Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
416 |
FunPep Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
417 |
Fusion Antibodies PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
418 |
Fusion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
419 |
Futura Medical PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
420 |
G1 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
421 |
Gain Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
422 |
Galapagos NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
423 |
Galecto Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
424 |
Galera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
425 |
Galmed Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
426 |
GemPharmatech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
427 |
Genelux Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
428 |
Genematrix Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
429 |
Genenta Science SPA (ADR) (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
430 |
Generation Bio Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
431 |
GeneTether Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
432 |
Genetic Analysis AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
433 |
GeNeuro SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
434 |
Genexine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
435 |
Genmab A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
436 |
Genome&Company (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
437 |
GENOMED SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
438 |
Genomic Vision SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
439 |
Genomics Bioscience & Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
440 |
Genomictree Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
441 |
Genomtec SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
442 |
Genor Biopharma Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
443 |
genOway SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
444 |
Genprex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
445 |
Genscript Biotech Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
446 |
Gensight Biologics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
447 |
Genus plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
448 |
Genxone SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
449 |
Geovax Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
450 |
Gevo Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
451 |
GFC Green Fields Capital Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
452 |
GH Research PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
453 |
GI Innovation Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
454 |
Ginkgo Bioworks Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
455 |
GL Pharm Tech Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
456 |
Global Bioenergies SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
457 |
Glow Lifetech Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
458 |
GlycoMimetics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
459 |
GlycoNex Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
460 |
Glycorex Transplantation AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
461 |
GNI Group Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
462 |
GNT Biotech & Medicals Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
463 |
Golden Biotechnology Corp. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
464 |
Goldenwell Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
465 |
Gongwin Biopharm Holdings Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
466 |
Gossamer Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
467 |
Grace Therapeutics, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
468 |
Gracell Biotechnologies Inc (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
469 |
GRAIL Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
470 |
Greenlight Biosciences Holdings PBC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
471 |
Greenwich Lifesciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
472 |
GRI Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
473 |
Gubra A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
474 |
Hamlet BioPharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
475 |
Hangzhou Bio-sncrty Phrm-tch Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
476 |
Hangzhou Tigermed Consulting Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
477 |
Hansa Biopharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
478 |
Harpoon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
479 |
HBL Hadasit Bio Holdings Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
480 |
Hcw Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
481 |
Healios KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
482 |
Heartseed Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
483 |
Heidelberg Pharma AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
484 |
Helix Biopharma Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
485 |
HEM Pharma Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
486 |
Hemogenyx Pharmaceuticals PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
487 |
Hemostemix Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
488 |
Hepion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
489 |
Herantis Pharma Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
490 |
Hexima Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
491 |
Hi-Great Group Holding Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
492 |
HighTide Therapeutics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
493 |
Hillevax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
494 |
HitGen Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
495 |
HLB Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
496 |
Holista Colltech Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
497 |
Hua Medicine (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
498 |
Human Metabolome Technologies Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
499 |
hVIVO PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
500 |
Hyenergy SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
501 |
Hyundai ADM Bio lnc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
502 |
IBEX Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
503 |
Ibio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
504 |
ICON PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
505 |
Icosavax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
506 |
IDT Australia Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
507 |
IGC Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
508 |
Ikena Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
509 |
Imgt Corp Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
510 |
Immatics NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
511 |
Immuneering Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
512 |
Immunic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
513 |
Immunitybio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
514 |
Immunotech Biopharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
515 |
Immunovant Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
516 |
Immunovia AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
517 |
ImmuPharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
518 |
Immutep Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
519 |
Imugene Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
520 |
IN8BIO, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
521 |
Inalways Corporation (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
522 |
Incanthera PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
523 |
Incyte Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
524 |
Indaptus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
525 |
Inflarx NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
526 |
Inhibikase Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
527 |
Inhibitor Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
528 |
Inhibrx Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
529 |
Initiator Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
530 |
INmune Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
531 |
Innoveren Scientific Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
532 |
Innovotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
533 |
Inotiv Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
534 |
Inozyme Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
535 |
Instil Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
536 |
Intech Biopharm Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
537 |
IntegraGen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
538 |
Intellia Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
539 |
Intensity Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
540 |
Invap SE (Argentina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
541 |
Inventionmed SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
542 |
InventisBio Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
543 |
Inventiva SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
544 |
Invex Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
545 |
Invion Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
546 |
Invivyd Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
547 |
Invizyne Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
548 |
IO Biotech Inc (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
549 |
Iovance Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
550 |
IPI Legacy Liquidation Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
551 |
Iqvia Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
552 |
IQVIA RDS Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
553 |
Island Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
554 |
ispace Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
555 |
iTeos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
556 |
Iterum Therapeutics PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
557 |
IXICO plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
558 |
Jacobio Pharmaceuticals Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
559 |
Janux Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
560 |
Jasper Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
561 |
Jeevan Scientific Technology Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
562 |
Jiangsu Yahong Meditech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
563 |
Joby Aviation Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
564 |
Joinn Laboratories China Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
565 |
Jounce Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
566 |
Jupiter Neurosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
567 |
JW (Cayman) Therapeutics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
568 |
Jyong Biotech Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
569 |
Kadimastem Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
570 |
Kainos Medicine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
571 |
Kairos Pharma Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
572 |
Kalvista Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
573 |
Kang Stem Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
574 |
Karuna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
575 |
Karyopharm Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
576 |
Kazia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
577 |
KBR Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/27/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
578 |
KDA Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
579 |
Keros Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
580 |
Kezar Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
581 |
Kidswell Bio Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
582 |
Kineta Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
583 |
Kinnate Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
584 |
Kintor Pharmaceutical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
585 |
Kiora Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
586 |
Kiromic Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
587 |
Klaria Pharma Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
588 |
Kodiak Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
589 |
Kolon TissueGene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
590 |
Korro Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
591 |
Kringle Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
592 |
Kronos Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
593 |
Krystal Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
594 |
Kuros Biosciences AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
595 |
Kymera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
596 |
Kyverna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
597 |
Laekna Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
598 |
Landos Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
599 |
Lantern Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
600 |
Larimar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
601 |
LAVA Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
602 |
Leap Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
603 |
Legend Biotech Corp (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
604 |
Lenz Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
605 |
Lexeo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
606 |
LianBio - ADR (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
607 |
Lidds AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
608 |
LigaChem Biosciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
609 |
Liminal BioSciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
610 |
Linical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
611 |
Lipella Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
612 |
Lipocine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
613 |
Lipum AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
614 |
Liquidia Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
615 |
Lirum Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
616 |
Lisata Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
617 |
Locus Cell Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
618 |
Longboard Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
619 |
Longeveron Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
620 |
Lophos Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
621 |
LTR Pharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
622 |
LTT Bio-Pharma Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
623 |
Lumosa Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
624 |
Luna Innovations Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
625 |
LungLife AI Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
626 |
Lyell Immunopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
627 |
Lyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
628 |
Lytix Biopharma AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
629 |
Maat Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
630 |
Mabion SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
631 |
Macrogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
632 |
MacroGenics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
633 |
Madrigal Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
634 |
Maia Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
635 |
Manuka Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
636 |
Many Bright Ideas Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
637 |
Marinus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
638 |
Matinas BioPharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
639 |
Matricelf Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
640 |
Mavens Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
641 |
MBX Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
642 |
MDxHealth SA - ADR (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
643 |
Medesis Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
644 |
Medical Data Vision Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
645 |
Medicenna Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
646 |
Medicofarma Biotech SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
647 |
Medicure Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
648 |
Medigen Biotechnology Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
649 |
MediGene AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
650 |
Medinet Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
651 |
Medipost Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
652 |
Medivir AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
653 |
Medizen Humancare Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
654 |
Medlab Clinical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
655 |
Medpace Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
656 |
Medpacto Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
657 |
MEDRx Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
658 |
Megapro Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
659 |
Mendus AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
660 |
Mersana Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
661 |
Merus NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
662 |
Mesoblast Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
663 |
MetaVia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
664 |
Microbix Biosystems Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
665 |
Microwave Chemical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
666 |
Milestone Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
667 |
Millennium Food-Tech LP (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
668 |
Mind Medicine (MindMed) Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
669 |
Mineralys Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
670 |
Mink Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
671 |
Mira Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
672 |
Mirati Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
673 |
Miromatrix Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
674 |
Mirum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
675 |
Modalis Therapeutics Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
676 |
Moderna Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
677 |
Modus Therapeutics Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
678 |
Molecular Partners AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
679 |
Moleculin Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
680 |
Monopar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
681 |
Monte Rosa Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
682 |
Moogene Medi Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
683 |
Moolec Science SA (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
684 |
Morphic Holding Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
685 |
MorphoSys AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
686 |
Movano Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
687 |
Mural Oncology PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
688 |
Mustang Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
689 |
Mycotopia Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
690 |
Mydecine Innovations Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
691 |
N4 Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
692 |
Nabriva Therapeutics PLC - ADR (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
693 |
Nano Mrna Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
694 |
Nanobiotix SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
695 |
Nanogroup SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
696 |
Nanotech Indonesia Global Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
697 |
NanoViricides Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
698 |
Nascent Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
699 |
National Research Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
700 |
NatureCell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
701 |
Nautilus Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
702 |
Neoimmunetech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
703 |
Neonc Technologies Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
704 |
Neovacs SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
705 |
Neumora Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
706 |
Neurogene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
707 |
Neuroscientific Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
708 |
Neurosense Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
709 |
Neurotech International Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
710 |
Newron Pharmaceuticals SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
711 |
Neximmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
712 |
Next Science Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
713 |
Nextage Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
714 |
NextCell Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
715 |
NextCure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
716 |
Nfl Biosciences SAS (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
717 |
NGM Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
718 |
Nidhogg Resources Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
719 |
Nightingale Health Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
720 |
Nirvana Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
721 |
NKMax Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
722 |
NLS Pharmaceutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
723 |
Noile-Immune Biotech Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
724 |
Northwest Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
725 |
Notable Labs Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
726 |
NOUL Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
727 |
Novelstem International Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
728 |
Novomics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
729 |
Noxopharm Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
730 |
NRX Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
731 |
NuCana PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
732 |
Numinus Wellness Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
733 |
Nurexone Biologic Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
734 |
Nuvalent Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
735 |
Nuvation Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
736 |
Nuvectis Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
737 |
Nykode Therapeutics ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
738 |
OBI Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
739 |
Obseva SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
740 |
Oculis Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
741 |
OKYO Pharma Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
742 |
Olema Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
743 |
OliX Pharmaceuticals Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
744 |
Omega Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
745 |
OmniAB Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
746 |
OncoCross Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
747 |
Oncolys Biopharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
748 |
OncoTherapy Science, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
749 |
Onemednet Corp (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
750 |
Onkure Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
751 |
Opthea Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
752 |
OptiBiotix Health PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
753 |
Optimind Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
754 |
ORIC Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
755 |
Oryzon Genomics SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
756 |
OS Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
757 |
Ose Immunotherapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
758 |
Outlook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
759 |
Ovid Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
760 |
Ovoca Bio PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
761 |
Oxford BioMedica plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
762 |
Oxurion NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
763 |
P3 Health Partners Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
764 |
Pacific Edge Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
765 |
Palisade Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
766 |
Pangaea Oncology SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
767 |
PanGen Biotech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
768 |
Paradigm Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
769 |
Pardes Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
770 |
Pasithea Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
771 |
Passage Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
772 |
Patrys Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
773 |
PaxMedica Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
774 |
PCI Biotech Holding ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
775 |
PDS Biotechnology Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
776 |
Peak Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
777 |
Peijia Medical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
778 |
Pell Bio Med Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
779 |
PepGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
780 |
Peptidream Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
781 |
Peptonic Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
782 |
Percheron Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
783 |
Personalis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
784 |
Petros Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
785 |
Pharma Mar SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
786 |
PharmAbcine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
787 |
Pharmadax Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
788 |
PharmaEngine Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
789 |
Pharmala Biotech Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
790 |
PharmaResearch Bio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
791 |
PharmaResources Shanghai Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
792 |
Pharmigene Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
793 |
Pharvaris NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
794 |
Phathom Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
795 |
Phenomex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
796 |
Philogen SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
797 |
PhoenixBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
798 |
Phytohealth Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
799 |
Plant Advanced Technologies PAT SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
800 |
Plantarc Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
801 |
POINT Biopharma Global Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
802 |
Point of Care Nano-Technology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
803 |
Polaris Group LLC (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
804 |
Poltreg SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
805 |
Polyrizon Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
806 |
Pond Technologies Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
807 |
Poolbeg Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
808 |
Poseida Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
809 |
Poxel SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
810 |
PRA Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
811 |
Praxis Precision Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
812 |
Precision BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
813 |
Predilife SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
814 |
Prelude Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
815 |
Prestige Biopharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
816 |
Prime Medicine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
817 |
PRISM BioLab Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
818 |
Private Rented Sector SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
819 |
ProKidney Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
820 |
Promimic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
821 |
Promis Neurosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
822 |
ProQR Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
823 |
Protagonist Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
824 |
Protara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
825 |
Proteomics International LaboratoriesLtd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
826 |
Psomagen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
827 |
Psybio Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
828 |
Psyence Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
829 |
Pulmatrix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
830 |
Pure Biologics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
831 |
Puretech Health PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
832 |
PYC Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
833 |
Qrons Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
834 |
Qualigen Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
835 |
Quantum BioPharma Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
836 |
Quantum Genomics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
837 |
Quest PharmaTech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
838 |
Quince Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
839 |
Quoin Pharmaceuticals Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
840 |
Qyuns Therapeutics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
841 |
Race Oncology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
842 |
Radius Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
843 |
Rain Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
844 |
Rakovina Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
845 |
Rallybio Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
846 |
Ramm Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
847 |
Rani Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
848 |
Raphael Pharmaceutical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
849 |
Rapid Nutrition PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
850 |
Rapport Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
851 |
Rapt Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
852 |
RaQualia Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
853 |
RayzeBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
854 |
Read Gene SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
855 |
Realbotix Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
856 |
Recursion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
857 |
Redx Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
858 |
Regencell Bioscience Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
859 |
Regenxbio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
860 |
Regulus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
861 |
RELIEF THERAPEUTICS Holding SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
862 |
Relmada Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
863 |
ReNeuron Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
864 |
Renovaro Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
865 |
RenovoRx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
866 |
Repare Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
867 |
RepliCel Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
868 |
Replimune Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
869 |
Restart Life Sciences Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
870 |
Resverlogix Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
871 |
RetinalGenix Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
872 |
Revelation Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
873 |
Reviva Pharmaceuticals Holdings, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
874 |
Revive Therapeutics Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
875 |
Revolution Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
876 |
Rhythm Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
877 |
Ribomic Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
878 |
Rocket Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
879 |
Roivant Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
880 |
Ryvu Therapeutics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
881 |
SAB Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
882 |
SAGE Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
883 |
Sailong Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
884 |
Sana Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
885 |
SanBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
886 |
Saniona AB (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
887 |
Sareum Holdings Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
888 |
Satellos Bioscience Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
889 |
Scancell Holdings Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
890 |
Scholar Rock Holding Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
891 |
Science 37 Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
892 |
Scinai Immunotherapeutics Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
893 |
SCM LifeScience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
894 |
Scopus Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
895 |
Sds Optic SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
896 |
Selvita SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
897 |
Senhwa Biosciences Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
898 |
Sensei Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
899 |
Sensorion SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
900 |
Senti Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
901 |
SenzaGen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
902 |
Seoulin Bioscience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
903 |
Seres Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
904 |
Sernova Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
905 |
Serodus AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
906 |
Shanghai Aladdin Biochemical Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
907 |
Shanghai Medicilon Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
908 |
Shanxi Jinbo Bio-pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
909 |
Shaperon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
910 |
Shattuck Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
911 |
Shield Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
912 |
Shin Nippon Biomedical Laboratories Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
913 |
Shine-On BioMedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
914 |
Shree Ganesh Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
915 |
Shuttle Pharmaceuticals Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
916 |
Sichuan Kelun-Biotech Biophrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
917 |
Silence Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
918 |
Silexion Therapeutics Corp (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
919 |
SillaJen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
920 |
SINEW Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
921 |
Sino Biological Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
922 |
Sinocelltech Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
923 |
Sirona Biochem Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
924 |
Skinbiotherapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
925 |
Skye Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
926 |
Sofiva Genomics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
927 |
Sol Gel Technologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
928 |
Solar Foods Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
929 |
Solarvest Bioenergy Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
930 |
Soleno Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
931 |
Somalogic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
932 |
Sona Nanotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
933 |
Sonnet Biotherapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
934 |
Spago Nanomedical AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
935 |
Spero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
936 |
Spexis AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
937 |
SpringWorks Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
938 |
Sprint Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
939 |
Spruce Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
940 |
Spyre Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
941 |
SQZ Biotechnologies Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
942 |
SS Innovations International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
943 |
StageZero Life Sciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
944 |
Starpharma Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
945 |
Stayble Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
946 |
Steakholder Foods Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
947 |
Stem Cells Spin SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
948 |
Steminent Biotherapeutics Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
949 |
StimCell Enegetics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
950 |
Stoke Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
951 |
Storage Drop Storage Technologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
952 |
Strategic Partners A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
953 |
Structure Therapeutics Inc (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
954 |
Sun Pharma Advanced Research Co Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
955 |
Sunho Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
956 |
Sunmax Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
957 |
Surface Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
958 |
Suven Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
959 |
Sygnis SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
960 |
Synairgen plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
961 |
Synaptogenix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
962 |
Syndax Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
963 |
Syneos Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
964 |
SyneuRx International (Taiwan) Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
965 |
Syngene International Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
966 |
Synlogic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
967 |
Syntara Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
968 |
SyntheticMR AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
969 |
Synthon BV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
970 |
Syros Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
971 |
TaiGen Biopharmaceuticals Holdings Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
972 |
TaiMed Biologics Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
973 |
TaiRx Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
974 |
Taiwan Bio Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
975 |
TaiwanJ Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
976 |
Takara Bio Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
977 |
Take Solutions Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
978 |
Talis Biomedical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
979 |
Talisker Resources Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
980 |
Tango Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
981 |
Tanvex BioPharma Inc (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
982 |
Taysha Gene Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
983 |
TC Biopharm (Holdings) PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
984 |
Tectonic Therapeutic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
985 |
Telix Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
986 |
Telo Genomics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
987 |
Tempest Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
988 |
Tenax Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
989 |
Tenaya Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
990 |
Terns Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
991 |
Terragen Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
992 |
TFF Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
993 |
Tharimmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
994 |
TheraCryf PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
995 |
Theralink Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
996 |
Theranexus SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
997 |
Therapeutic Solutions International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
998 |
Therma Bright Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
999 |
Theseus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,000 |
Thiogenesis Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,001 |
Thor Medical ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,002 |
Tissue Repair Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,003 |
TiumBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,004 |
Tiziana Life Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,005 |
Tiziana Life Sciences Ltd - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,006 |
TME Pharma NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,007 |
TMS Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,008 |
TNF Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,009 |
Toleranzia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,010 |
Tonix Pharmaceuticals Holding Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,011 |
ToolGen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,012 |
Tourmaline Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,013 |
TRACON Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,014 |
Transcode Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,015 |
Transgene Biotek Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,016 |
Traws Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,017 |
Trevi Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,018 |
Trex Wind-Down Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,019 |
Tryp Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/29/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,020 |
Tryptamine Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,021 |
Tsubota Laboratory Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,022 |
TuHURA Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,023 |
Twi Biotechnology Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,024 |
TYK Medicines Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,025 |
Tyra Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,026 |
Ulisse Biomed Spa (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,027 |
Unicocell Biomed Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,028 |
Unicycive Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,029 |
Uniqure NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,030 |
Unity Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,031 |
Urogen Pharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,032 |
Urteste SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,033 |
Vaccinex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,034 |
Valbiotis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,035 |
ValiRx Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,036 |
Vanta Bioscience Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,037 |
Vaxcyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,038 |
Vaxil Bio Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,039 |
Vaxxinity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,040 |
VBI Vaccines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,041 |
Vectus Biosystems Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,042 |
Verastem Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,043 |
Veritas In Silico Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,044 |
Verona Pharma PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,045 |
Verve Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,046 |
Vicarious Surgical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,047 |
ViGenCell Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,048 |
Vigil Neuroscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,049 |
Viking Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,050 |
Vimta Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,051 |
Vir Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,052 |
ViroGates A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,053 |
Virpax Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,054 |
Vistagen Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,055 |
VIVA Biotech Holdings (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,056 |
Vivakor inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,057 |
Vivo Bio Tech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,058 |
Vivoryon Therapeutics NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,059 |
VO2 Cap Holding publ AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,060 |
VolitionRX Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,061 |
Vor Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,062 |
Voyager Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,063 |
vTv Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,064 |
Vyne Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,065 |
Vytrus Biotech SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,066 |
Wave Life Sciences Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,067 |
Waverley Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,068 |
Welgene Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,069 |
Wellfully Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,070 |
Wilk Technologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,071 |
Willow Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,072 |
Wntresearch AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,073 |
WPD Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,074 |
WuXi AppTec Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,075 |
X T L Biopharmaceuticals Ltd (ADR) (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,076 |
X4 Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,077 |
XBiotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,078 |
Xbrane Biopharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,079 |
Xencor Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,080 |
Xenon Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,081 |
Xeris Biopharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,082 |
Xilio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,083 |
Xinjiang Bai Hua Cun Pharma Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,084 |
Xintela AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,085 |
XSpray Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,086 |
XtalPi Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,087 |
Y Biologics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,088 |
Yield10 Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,089 |
Yubo International Biotech Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,090 |
Zealand Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,091 |
Zelira Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,092 |
Zenas Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,093 |
Zenith Capital Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,094 |
Zentek Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,095 |
Zevra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,096 |
Zosano Pharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,097 |
Zura Bio Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,098 |
Zymeworks Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,099 |
Zynerba Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
1,100 |
ZYUS Life Sciences Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |